Etienne Côté
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Etienne Côté has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
M. Dirven
Evidensia Södra Animal Hospital, Kungens Kurva, Sweden
3 shared publications- Mark Rishniw
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY
3 shared publications - Momo Yu-Wen Kuo
Department of Clinical Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, Uppsala, Sweden
3 shared publications T.-L. Lu
Chuan Animal Hospital, Taipei, Taiwan
3 shared publicationsChick Weisse
Department of Companion Animals (Feyler, Côté) and Department of Biomedical Sciences (Dawson), Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, Prince Edward Island C1A 4P3; Department of Interventional Radiology and Interventional Endoscopy, Schwarzman Animal Medical Center, 510 East 62nd Street, New York, New York 10065, USA (Weisse)
2 shared publicationsDeepmala Agarwal
Department of Companion Animals, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, Canada
2 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (4) , 427-432
Effects of Oral Single‐Dose Empagliflozin on Urinary Glucose, Serum β‐Hydroxybutyrate, and Plasma Empagliflozin Concentrations in Healthy Adult Dogs
Empagliflozin is a sodium‐glucose cotransporter‐2 inhibitor used for treating humans with heart failure, among other conditions. This drug could have applications in veterinary cardiology, but whether empagliflozin has biological effects in dogs when administered at dosages approximating human therapeutic dosages is unknown. This study investigated whether empagliflozin (target dosage, 0.3 mg/kg) could produce significant increases in urinary glucose concentrations and measurable plasma drug concentrations, without increasing serum β‐hydroxybutyrate (β‐HA) concentrations in dogs. Six healthy, privately‐owned dogs weighing 22–36 kg were studied prospectively. Urinary glucose, serum β‐HA, and plasma empagliflozin concentrations were measured 0 h, 6 h, 12 h, 24 h, 48 h, and 72 h after single‐dose oral administration of 10 mg empagliflozin. The dosage administered was 0.28–0.45 mg/kg. Mean urinary glucose concentration peaked at 24 h (8,041 mg/dL) before returning to baseline (< 40 mg/dL) at 72 h ( p < 0.001). Serum β‐HA concentrations remained within the reference interval for dogs (< 2.1 mg/dL). Plasma drug concentrations at 24 h were 13 times greater than the reported human in vitro IC50. The half‐life was 4.4–6 h. Oral empagliflozin 0.28–0.45 mg/kg produced glucosuria and measurable plasma drug concentrations in healthy dogs, without ketonemia, after a single dose.
- 19 March 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (4) , 427-432
Open AccessEffects of Oral Single‐Dose Empagliflozin on Urinary Glucose, Serum β‐Hydroxybutyrate, and Plasma Empagliflozin Concentrations in Healthy Adult Dogs
Empagliflozin is a sodium‐glucose cotransporter‐2 inhibitor used for treating humans with heart failure, among other conditions. This drug could have applications in veterinary cardiology, but whether empagliflozin has biological effects in dogs when administered at dosages approximating human therapeutic dosages is unknown. This study investigated whether empagliflozin (target dosage, 0.3 mg/kg) could produce significant increases in urinary glucose concentrations and measurable plasma drug concentrations, without increasing serum β‐hydroxybutyrate (β‐HA) concentrations in dogs. Six healthy, privately‐owned dogs weighing 22–36 kg were studied prospectively. Urinary glucose, serum β‐HA, and plasma empagliflozin concentrations were measured 0 h, 6 h, 12 h, 24 h, 48 h, and 72 h after single‐dose oral administration of 10 mg empagliflozin. The dosage administered was 0.28–0.45 mg/kg. Mean urinary glucose concentration peaked at 24 h (8,041 mg/dL) before returning to baseline (< 40 mg/dL) at 72 h ( p < 0.001). Serum β‐HA concentrations remained within the reference interval for dogs (< 2.1 mg/dL). Plasma drug concentrations at 24 h were 13 times greater than the reported human in vitro IC50. The half‐life was 4.4–6 h. Oral empagliflozin 0.28–0.45 mg/kg produced glucosuria and measurable plasma drug concentrations in healthy dogs, without ketonemia, after a single dose.
- Open Access
- 28 July 2025
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 62, 1-16
Veterinary echocardiographers’ preferences for image selection, timing, and caliper placement for left atrial two-dimensional size assessment in dogs: the BENEFIT project
- 28 July 2025
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 62, 1-16
Open AccessVeterinary echocardiographers’ preferences for image selection, timing, and caliper placement for left atrial two-dimensional size assessment in dogs: the BENEFIT project
- 1 March 2025
- Vol. 66 (3) , 298-307
Computed tomographic angiographic study of common carotid artery anatomic relationships in the dog.
To further understand spatial relationships of common carotid arteries to adjacent structures through evaluation of computed tomographic angiograms in dogs. 24 pet dogs. A database was searched for triplanar computed tomographic angiograms that included the heart base caudally and the 5th cervical vertebra cranially, without macroscopic abnormalities. Measurements included brachiocephalic trunk length, common carotid arteries' position relative to the trachea, transverse (axial) thoracic height and width, manubrium length, and length of the 7th cervical vertebra (C7). Measurements (mean + SD) included brachiocephalic trunk length = 3.65 ± 1.34 cm (n = 24), mean thoracic inlet height = 6.51 ± 2.03 cm (n = 23), mean thoracic inlet width = 4.69 ± 1.35 cm (n = 20), mean manubrium length = 3.52 ± 1.15 cm (n = 22), and mean length of C7 = 1.93 ± 0.46 cm (n = 23). Some or all measurements were feasible in all dogs. Understanding interindividual variation in spatial relationships is pertinent to differentiating normal from abnormal, for surgical planning, and possibly for elucidating the pathogenesis of certain disorders. It is possible to obtain these measurements in dogs. This technique could be applied to subgroups of dogs (e.g., breeds) and dogs with cervical or thoracic abnormalities.
- 1 March 2025
- Vol. 66 (3) , 298-307
Computed tomographic angiographic study of common carotid artery anatomic relationships in the dog.
To further understand spatial relationships of common carotid arteries to adjacent structures through evaluation of computed tomographic angiograms in dogs. 24 pet dogs. A database was searched for triplanar computed tomographic angiograms that included the heart base caudally and the 5th cervical vertebra cranially, without macroscopic abnormalities. Measurements included brachiocephalic trunk length, common carotid arteries' position relative to the trachea, transverse (axial) thoracic height and width, manubrium length, and length of the 7th cervical vertebra (C7). Measurements (mean + SD) included brachiocephalic trunk length = 3.65 ± 1.34 cm (n = 24), mean thoracic inlet height = 6.51 ± 2.03 cm (n = 23), mean thoracic inlet width = 4.69 ± 1.35 cm (n = 20), mean manubrium length = 3.52 ± 1.15 cm (n = 22), and mean length of C7 = 1.93 ± 0.46 cm (n = 23). Some or all measurements were feasible in all dogs. Understanding interindividual variation in spatial relationships is pertinent to differentiating normal from abnormal, for surgical planning, and possibly for elucidating the pathogenesis of certain disorders. It is possible to obtain these measurements in dogs. This technique could be applied to subgroups of dogs (e.g., breeds) and dogs with cervical or thoracic abnormalities.
- Open Access
- 30 August 2024
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 56, 56-64
Cardiac biomarker profiles in dogs with naturally occurring precapillary pulmonary hypertension
- 30 August 2024
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 56, 56-64
Open AccessCardiac biomarker profiles in dogs with naturally occurring precapillary pulmonary hypertension
- Open Access
- 10 November 2023
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 51, 157-171
Veterinary echocardiographers' preferences for left atrial size assessment in dogs: the BENEFIT project
- 10 November 2023
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 51, 157-171
Open AccessVeterinary echocardiographers' preferences for left atrial size assessment in dogs: the BENEFIT project
- Open Access
- 9 November 2023
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 51, 145-156
Veterinary echocardiographers' preferences for left atrial size assessment in cats: the BENEFIT project
- 9 November 2023
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 51, 145-156
Open AccessVeterinary echocardiographers' preferences for left atrial size assessment in cats: the BENEFIT project
- 1 September 2023
- Vol. 64 (9) , 864-870
Serum C-terminal telopeptide of Type-I collagen (CTx) concentration and myocardial hyperechogenicity in cats with hypertrophic cardiomyopathy
This study sought to determine the serum concentrations of C-terminal telopeptide of Type-I collagen (CTx), a marker of collagen degradation, in a hospital population of cats with hypertrophic cardiomyopathy (HCM). The study also evaluated the prevalence of myocardial hyperechogenicity of the left ventricle (LV) in the same cats. Cats brought to a university veterinary cardiology service entered the study when they had an echocardiographic diagnosis of HCM; echocardiographically normal cats served as controls. Serum CTx concentrations were assessed using ELISA. There was no difference in serum CTx concentrations between cats with HCM and controls (HCM: median 0.248 ng/mL, controls: median 0.253 ng/mL; P = 0.4). Significantly more cats with HCM (60%) showed echocardiographic LV myocardial hyperechogenicity compared to normal controls (17%; P = 0.0057), but serum CTx concentrations were not different between these 2 groups. These results indicate that, as in human patients with HCM and in contrast to earlier feline studies, there was no evidence of enhanced collagen degradation indicated by serum CTx concentrations in cats with HCM compared to normal controls.
- 1 September 2023
- Vol. 64 (9) , 864-870
Serum C-terminal telopeptide of Type-I collagen (CTx) concentration and myocardial hyperechogenicity in cats with hypertrophic cardiomyopathy
This study sought to determine the serum concentrations of C-terminal telopeptide of Type-I collagen (CTx), a marker of collagen degradation, in a hospital population of cats with hypertrophic cardiomyopathy (HCM). The study also evaluated the prevalence of myocardial hyperechogenicity of the left ventricle (LV) in the same cats. Cats brought to a university veterinary cardiology service entered the study when they had an echocardiographic diagnosis of HCM; echocardiographically normal cats served as controls. Serum CTx concentrations were assessed using ELISA. There was no difference in serum CTx concentrations between cats with HCM and controls (HCM: median 0.248 ng/mL, controls: median 0.253 ng/mL; P = 0.4). Significantly more cats with HCM (60%) showed echocardiographic LV myocardial hyperechogenicity compared to normal controls (17%; P = 0.0057), but serum CTx concentrations were not different between these 2 groups. These results indicate that, as in human patients with HCM and in contrast to earlier feline studies, there was no evidence of enhanced collagen degradation indicated by serum CTx concentrations in cats with HCM compared to normal controls.
- Open Access
- 1 September 2023
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 37 (5) , 1667-1678
Investigation of the cardiac effects of exercise testing on apparently healthy Boxer dogs
Background: Holter electrocardiographic monitoring is a cornerstone of diagnostic testing for arrhythmogenic cardiomyopathy (ACM) in Boxer dogs, but physical activity during monitoring is not controlled. In humans, exercise testing (ExT) can identify latent tachyarrhythmias associated with cardiomyopathy, and exercise increases serum cardiac troponin-I concentrations ([hs-cTnI]). These effects have not yet been investigated in Boxer dogs. Hypothesis/Objectives: Subjecting Boxer dogs to brief, moderate-intensity ExT can identify changes in Holter recordings and [hs-cTnI] compared to baseline results. Animals: Thirty overtly healthy, client-owned Boxer dogs. Methods: Prospective interventional study. Dogs underwent baseline diagnostic testing including 24-hour Holter monitoring and [hs-cTnI], followed by brief ExT (accompanied, brisk stair-climbing and -descending for 100 premature ventricular complexes (PVCs)/24 hours at baseline (3), ExT (3), or both (5). After ExT, these dogs had more PVCs/24 hours and greater increases in [hs-cTnI] compared to those with ≤100 PVCs/24 hours. Dogs with the striatin mutation had more PVCs/24 hours and a greater increase in [hs-cTnI] after ExT than did dogs without the striatin mutation. Conclusions and Clinical Importance: Exercise testing may improve the binary classification of Boxer dogs with or without ACM by increasing the number of PVCs and [hs-cTnI] in affected dogs to a greater degree than in unaffected dogs. This effect also is associated with presence or absence of the striatin mutation. Exercise should be a controlled variable when screening Boxer dogs for ACM.
- 1 September 2023
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 37 (5) , 1667-1678
Open AccessInvestigation of the cardiac effects of exercise testing on apparently healthy Boxer dogs
Background: Holter electrocardiographic monitoring is a cornerstone of diagnostic testing for arrhythmogenic cardiomyopathy (ACM) in Boxer dogs, but physical activity during monitoring is not controlled. In humans, exercise testing (ExT) can identify latent tachyarrhythmias associated with cardiomyopathy, and exercise increases serum cardiac troponin-I concentrations ([hs-cTnI]). These effects have not yet been investigated in Boxer dogs. Hypothesis/Objectives: Subjecting Boxer dogs to brief, moderate-intensity ExT can identify changes in Holter recordings and [hs-cTnI] compared to baseline results. Animals: Thirty overtly healthy, client-owned Boxer dogs. Methods: Prospective interventional study. Dogs underwent baseline diagnostic testing including 24-hour Holter monitoring and [hs-cTnI], followed by brief ExT (accompanied, brisk stair-climbing and -descending for 100 premature ventricular complexes (PVCs)/24 hours at baseline (3), ExT (3), or both (5). After ExT, these dogs had more PVCs/24 hours and greater increases in [hs-cTnI] compared to those with ≤100 PVCs/24 hours. Dogs with the striatin mutation had more PVCs/24 hours and a greater increase in [hs-cTnI] after ExT than did dogs without the striatin mutation. Conclusions and Clinical Importance: Exercise testing may improve the binary classification of Boxer dogs with or without ACM by increasing the number of PVCs and [hs-cTnI] in affected dogs to a greater degree than in unaffected dogs. This effect also is associated with presence or absence of the striatin mutation. Exercise should be a controlled variable when screening Boxer dogs for ACM.
- 13 April 2022
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 260 (13) , 1-10
Computed tomographic assessment of principal bronchial anatomy in dogs of various thoracic conformations: 93 cases (2012–2017)
OBJECTIVE: To better understand spatial relationships between principal bronchi and other intrathoracic structures by use of CT images of dogs of various somatotypes. ANIMALS: 93 dogs that underwent thoracic CT. PROCEDURES: Information was collected from medical records regarding signalment and physical examination and echocardiographic findings. Two investigators recorded multiple measurements on a thoracic axial CT image from each dog. RESULTS: Thoracic height-to-width ratio (H:W) was associated with left principal bronchus (LPB) and right principal bronchus (RPB) H:W, aortic-LPB separation, focal LPB narrowing, and aortic-vertebral overlap. Thoracic H:W was not associated with dog age, weight, sex, or brachycephalic breed. Twenty-five (27%) dogs had focal LPB narrowing, compared with 5 (5%) dogs with focal RPB narrowing (P < 0.001). Ten of 25 dogs had overlap or contact between vertebrae, aorta, LPB, and heart, suggesting a cumulative compressive effect on the LPB, while 15 had LPB-aorta contact and lack of contact between the aorta and thoracic vertebrae, suggesting an aortic constrictive effect on the LPB. None had LPB narrowing without contact from surrounding structures. Inter-rater agreement was high. CLINICAL RELEVANCE: In dogs that underwent CT and were not selected for clinical suspicion of bronchial disease, principal bronchial morphology was associated with thoracic conformation. Focal LPB narrowing occurred more often than RPB narrowing. Focal LPB narrowing occurred with evidence of extraluminal compression, with or without contact between aorta and vertebrae. Brachycephalic breed could not be used for predicting thoracic H:W.
- 13 April 2022
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 260 (13) , 1-10
Computed tomographic assessment of principal bronchial anatomy in dogs of various thoracic conformations: 93 cases (2012–2017)
OBJECTIVE: To better understand spatial relationships between principal bronchi and other intrathoracic structures by use of CT images of dogs of various somatotypes. ANIMALS: 93 dogs that underwent thoracic CT. PROCEDURES: Information was collected from medical records regarding signalment and physical examination and echocardiographic findings. Two investigators recorded multiple measurements on a thoracic axial CT image from each dog. RESULTS: Thoracic height-to-width ratio (H:W) was associated with left principal bronchus (LPB) and right principal bronchus (RPB) H:W, aortic-LPB separation, focal LPB narrowing, and aortic-vertebral overlap. Thoracic H:W was not associated with dog age, weight, sex, or brachycephalic breed. Twenty-five (27%) dogs had focal LPB narrowing, compared with 5 (5%) dogs with focal RPB narrowing (P < 0.001). Ten of 25 dogs had overlap or contact between vertebrae, aorta, LPB, and heart, suggesting a cumulative compressive effect on the LPB, while 15 had LPB-aorta contact and lack of contact between the aorta and thoracic vertebrae, suggesting an aortic constrictive effect on the LPB. None had LPB narrowing without contact from surrounding structures. Inter-rater agreement was high. CLINICAL RELEVANCE: In dogs that underwent CT and were not selected for clinical suspicion of bronchial disease, principal bronchial morphology was associated with thoracic conformation. Focal LPB narrowing occurred more often than RPB narrowing. Focal LPB narrowing occurred with evidence of extraluminal compression, with or without contact between aorta and vertebrae. Brachycephalic breed could not be used for predicting thoracic H:W.
- 1 April 2022
- Vol. 63 (4) , 411-415
Mineralized, obstructive cardiac myxoma with chondroid differentiation in a cocker spaniel
A 12-year-old castrated male cocker spaniel dog was referred for evaluation of signs consistent with right-sided heart failure. Thoracic radiography revealed mineralization in the region of the right atrium. Echocardiography identified a mass partially filling the right atrium and right ventricle and obstructing flow through the right heart. These findings were confirmed at necropsy and histopathologic features were consistent with myxoma with chondroid differentiation.
- 1 April 2022
- Vol. 63 (4) , 411-415
Mineralized, obstructive cardiac myxoma with chondroid differentiation in a cocker spaniel
A 12-year-old castrated male cocker spaniel dog was referred for evaluation of signs consistent with right-sided heart failure. Thoracic radiography revealed mineralization in the region of the right atrium. Echocardiography identified a mass partially filling the right atrium and right ventricle and obstructing flow through the right heart. These findings were confirmed at necropsy and histopathologic features were consistent with myxoma with chondroid differentiation.